Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

43 results about "Hedysarum polybotrys" patented technology

Application of effective parts of astragalus mongholicus and hedysarum polybotrys

InactiveCN102885878AIncreased lung coefficientImproved lung coefficientOrganic active ingredientsRespiratory disorderHedysarumAstragalus mongholicus
The invention belongs to the traditional Chinese medicine field and relates to the preparation of effective parts of astragalus mongholicus and hedysarum polybotrys and selection thereof for pulmonary fibrosis model intervention so as to obtain further study on the effective parts having the optimal curative effect. An interstitial pulmonary fibrosis model of rats is established through modeling; and compared with the normal rats, the rats having interstitial pulmonary fibrosis have obvious difference and pathologic change typical cases in various related detection indexes and pathologic changes. The various effective parts of astragalus mongholicus and hedysarum polybotrys are capable of suppressing various related indexes of the interstitial pulmonary fibrosis model of rats induced by bleomycin and preventing the development of interstitial pulmonary fibrosis, wherein low and medium dose groups of hedysarum polybotrys flavone have the optimal effect. The degree of the effect of the effective parts of astragalus mongholicus and hedysarum polybotrys on stopping the progress of interstitial pulmonary fibrosis is related to appropriate concentrations of equivalent dugs. Through comprehensive assessment, the hedysarum polybotrys flavone is better in influence on the lung function, HA, LN, HYP and the like of the rats having interstitial pulmonary fibrosis than other effective parts.
Owner:GANSU UNIV OF CHINESE MEDICINE

Method for preparing hedysarum polybotrys extract by adopting coupling technology

The invention provides a method for preparing a hedysarum polybotrys extract by adopting a coupling technology. The method comprises the following steps of: carrying out heating reflux extracting on hedysarum polybotrys; adding commercially available pectinase in a water extracting solution with the temperature of 15-60 DEG C; carrying out enzymolysis and sedimentation; removing insoluble impurities to obtain an enzymolysis extracting solution; carrying out ultra-filtering on the enzymolysis extracting solution; or, directly carrying out ultra-filtering on the water extracting solution; carrying out ultra-filtering on diluted trapped fluid for 2-4 times under the same condition, i.e. diluting the trapped fluid subjected to ultra-filtering each time and then carrying out ultra-filtering on the diluted trapped fluid subjected to ultra-filtering, ensuring that the volume of the trapped fluid subjected to ultra-filtering for the last time does not exceed 20 percent of the volume of the enzymolysis extracting solution, and merging all filtrated solutions to obtain a total filtrated solution; carrying out nanofiltering and concentrating on the total filtrated solution; concentrating trapped fluid subjected to nanofiltering under reduced pressure, and drying to obtain a hedysarum polybotrys full-ingredient extract; or concentrating the trapped fluid subjected to nanofiltering to be an extracting solution with corresponding concentration for preparing liquid preparation. According to the method, the process period for preparing the hedysarum polybotrys extract can be effectively shortened, the production cost is reduced, the extract quality is improved, and environmental protection is favored.
Owner:魏舒畅

Method for using fluorescence to label hedysarum polybotrys saccharide and hedysarum polybotrys saccharide labeled through method and application of hedysarum polybotrys saccharide

InactiveCN107722130ANo obvious effect on the internal structureNo significant effect on biological activityIn-vivo testing preparationsLuminescent compositionsLuminophoreFluorophore
The invention provides a method for labeling the reduction terminal of hedysarum polybotrys saccharide (HPS) with a fluorescent substance being a probe and application of HPS labeled through the method in studying the aspects of quantitative analysis, cell locating, tissue distribution, oral taking absorption, metabolism and excretion, pharmacology and the mechanism of the pharmacology and the like of HPS. Properties of the reduction terminal of HPS are utilized, and through a reductive amination reaction, the reduction terminal is directly or indirectly reacted with the fluorescent substance,so that HPS is connected to fluorophores. By means of the method, HPS without luminophores becomes hedysarum polybotrys saccharide which is easy to detect and has fluorescence, and the labeling method does not obviously influence both the internal structure and the biological activity of HPS. HPS prepared and subjected to fluorescence labeling through the method can be used for basic study in theaspects of quantitative analysis, cell locating, tissue distribution, oral taking absorption, metabolism and excretion, pharmacology and the mechanism of the pharmacology and the like.
Owner:LANZHOU UNIVERSITY

Traditional Chinese medicine decoction for treating chronic renal failure and preparation method of traditional Chinese medicine decoction

InactiveCN105288339ASignificant effect in the treatment of chronic renal failureUnknown materialsUrinary disorderChronic kidney failureIlex cornuta
The invention relates to a traditional Chinese medicine decoction for treating a chronic renal failure and a preparation method of the traditional Chinese medicine decoction. The traditional Chinese medicine decoction is mainly prepared from the following raw materials in parts by weight: 10-20 parts of codonopsis pilosula, 4-9 parts of serissa serissoide, 8-16 parts of poria cocos, 2-6 parts of cassia twig, 10-16 parts of hedysarum polybotrys, 9-16 parts of coix seeds, 5-10 parts of eucommia ulmoides, 6-12 parts of folium ilicis cornutae, 7-15 parts of astragatus complanatus, 3-9 parts of honey-fried licorice roots, 2-7 parts of flavoniodes, 3-7 parts of gecko, 2-6 parts of fruits of belleric terminalia and 4-10 parts of seabuckthorn. The traditional Chinese medicine decoction disclosed by the invention has a significant treatment effect on the chronic renal failure, and is reasonable in compatibility and unique in composition; and a plurality of medicines work together to reach the efficacies of protecting kidney qi, nourishing the liver and kidneys, invigorating the spleen, supplementing qi, tonifying yin and yang, removing blood stasis and turbidity, warming the middle warmer and harmonizing the stomach, and is very suitable for patients with the chronic renal failure for taking.
Owner:济南超舜中药科技有限公司

Traditional Chinese medicine for treating pet dog body edema and preparation method thereof

The invention discloses a traditional Chinese medicine for treating pet dog body edema. The traditional Chinese medicine is prepared from, by weight, 6-10 parts of kalopanax septemlobus roots, 18-20 parts of girald acanthopanax bark, 6-8 parts of manyprickle acanthopanax roots, 3-6 parts of Japanese conehead herb, 7-11 parts of Sinodielisa yunnanensis Wolff roots, 13-15 parts of fistular onion leaves, 7-8 parts of pericarpium arecae, 6-9 parts of clam powder, 5-10 parts of grewia oligandra Pierre, 10-15 parts of kazinoki broussonetia, 15-20 parts of hedysarum polybotrys, 18-24 parts of water pepper fruit, 13-17 parts of lilies of the valley, 5-10 parts of ophiocephalus argus cantor meat, 12-18 parts of Japanese artemisia roots, 20-25 parts of negundo chastetree fruit, 9-15 parts of bombax ceiba roots, 7-16 parts of sambucus williamsii hance, 12-17 parts of luffa seeds, 10-15 parts of pine needles, 5-10 parts of wormseed mustard, 7-9 parts of sun euphorbia herb and 11-14 parts of anemarrhenae. The traditional Chinese medicine for treating pet dog body edema has the effects of inducing diuresis for removing edema and diminishing inflammation and relieving pain, can be used for effectively treating pet dog body edema, and is quick in curative effect and free of side effects.
Owner:WUHU LEISURELY NURSING SUPPLIES POLYTRON TECH INC

Traditional Chinese medicine for treating pancreatic cancer

The invention discloses a traditional Chinese medicine for treating pancreatic cancer. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight, 10-20 parts of ovateleaf holly bark, 5-12 parts of hedysarum polybotrys, 12-25 parts of rhizoma chuanxiong, 9-27 parts of white atractylodes rhizome, 3-9 parts of hog brake, 12-25 parts of common yam rhizome, 4-20 parts of hypericum ascyron, 5-12 parts of golden larch bark, 10-19 parts of semen strychni pulveratum, 3-9 parts of persimmon calyx, 6-18 parts of amorphophallus virosus, 4-12 parts of gypenoside, 8-19 parts of rhizoma cimicifugae, 5-20 parts of loofah sponges and 9-25 parts of tortoise. The traditional Chinese medicine can be individually used, can also be matched with radiotherapy and chemotherapy and has the functions of reducing a tumor in a short period, effectively controlling metastasis and diffusion of cancer cells, inhibiting growth of the cancer cells, avoiding side effects, treating and resisting the cancer, enhancing body immunity, relieving pain of a patient, stabilizing illness conditions, prolonging lifetime, increasing the proportion of clinical cure patients, preventing residual cancer cells from coming back and greatly reducing recurrence and metastasis.
Owner:范明月

Traditional Chinese medicine decoction for treating aplastic anemia and preparation method of traditional Chinese medicine decoction

InactiveCN105288213ASignificant effect in the treatment of aplastic anemiaBlood disorderExtracellular fluid disorderApocynum venetumPuerarin
The invention relates to a traditional Chinese medicine decoction for treating aplastic anemia and a preparation method of the traditional Chinese medicine decoction. The traditional Chinese medicine decoction is mainly prepared from the following raw materials in parts by weight: 10-20 parts of fructus broussonetiae, 5-10 parts of semen cuscutae, 8-14 parts of manyprickle acanthopanax roots, 10-16 parts of gynostemma pentaphylla, 7-15 parts of flatstem milkvetch seeds, 15-20 parts of hedysarum polybotrys, 13-26 parts of rabdosia rubescens, 3-7 parts of scrophularia ningpoensis, 11-17 parts of ixeris sonchifolia hance, 4-8 parts of dragon`s blood, 6-12 parts of puerarin, 3-10 parts of radix ophiopogonis, 2-8 parts of folium apocyni veneti, 7-14 parts of radix rehmanniae praeparata and 6-10 parts of dendrobium officinale. The traditional Chinese medicine decoction provided by the invention has a significant effect on aplastic anemia, and is reasonable in compatibility and unique in composition; a plurality of medicines work together to reach the efficacies of reinforcing the kidneys, strengthening resistance, tonifying the spleen, nourishing blood, clearing heat, nourishing yin, cooling blood for hemostasis and the like; the effective rate is 85.7%; and the traditional Chinese medicine decoction is very suitable for patients with aplastic anemia for taking.
Owner:济南超舜中药科技有限公司

Traditional Chinese medicine composition and novel anti-allergic medical polymer splint prepared from traditional Chinese medicine composition

The invention discloses a traditional Chinese medicine composition and a novel anti-allergic medical polymer splint prepared from the traditional Chinese medicine composition. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 5-10 parts of abelmoschus esculentus, 5-10 parts of abelmoschus manihot, 1-10 parts of dried alum, 1-10 parts of pratia nummularia, 1-10 parts of wild buckwheat rhizome, 1-10 parts of hedysarum polybotrys or astragalus membranaceus and 1-10 parts of borneol. According to the invention, the traditional Chinese medicines with the effects of clearing away heat and toxic materials, cooling blood and diminishing swelling and relaxing tendons and setting bones are combined with the medical polymer splint, so that the medical polymer splint has a remarkable effect on recovery and treatment of fracture patients while being used for orthopedic fixation, and has the effects of preventing, relieving and treating untoward effects such as skin itch and allergy of the patients. The medical polymer splint has the advantages of being good in air permeability, high in universality, high in hardness, good in permeability, good in plasticity, convenient to operate and the like, can be widely applied to treatment of common fractures or soft tissue injuries, and can be applied to auxiliary treatment of bone injuries or soft tissue injuries around surgical postoperative wounds.
Owner:郑州弘新医疗科技有限公司

Application of Effective Fractions of Astragalus and Radix Radix

InactiveCN102885878BIncreased lung coefficientImproved lung coefficientOrganic active ingredientsRespiratory disorderCurative effectInterstitial pulmonary fibrosis
The invention belongs to the traditional Chinese medicine field and relates to the preparation of effective parts of astragalus mongholicus and hedysarum polybotrys and selection thereof for pulmonary fibrosis model intervention so as to obtain further study on the effective parts having the optimal curative effect. An interstitial pulmonary fibrosis model of rats is established through modeling; and compared with the normal rats, the rats having interstitial pulmonary fibrosis have obvious difference and pathologic change typical cases in various related detection indexes and pathologic changes. The various effective parts of astragalus mongholicus and hedysarum polybotrys are capable of suppressing various related indexes of the interstitial pulmonary fibrosis model of rats induced by bleomycin and preventing the development of interstitial pulmonary fibrosis, wherein low and medium dose groups of hedysarum polybotrys flavone have the optimal effect. The degree of the effect of the effective parts of astragalus mongholicus and hedysarum polybotrys on stopping the progress of interstitial pulmonary fibrosis is related to appropriate concentrations of equivalent dugs. Through comprehensive assessment, the hedysarum polybotrys flavone is better in influence on the lung function, HA, LN, HYP and the like of the rats having interstitial pulmonary fibrosis than other effective parts.
Owner:GANSU UNIV OF CHINESE MEDICINE

Composite dipeptide ginseng-cistanche deserticola liquor, composite dipeptide ginseng and cistanche deserticola granules and processing method thereof

The invention relates to a composite dipeptide ginseng-cistanche deserticola liquor for warming and tonifying essence and qi in the kidney, a composite dipeptide ginseng-cistanche deserticola granules prepared by reutilizing and processing wastes generated by processing health-care liquor, and a processing method thereof. Specifically, the processing method comprises the following steps: respectively separating an ethanol extracting solution of red ginseng, hedysarum polybotrys, fructus psoraleae and cistanche deserticola, an alcoholization solution of pomegranate fruits, lotus plumule and mulberry fruits and an enzymatic hydrolysate of oyster peptide and red date peptide by using a roll type ultrafiltration membrane with the molecular weight of 50,000; processing and drying the separated material liquid with the molecular weight of less than 50,000 to prepare the health-preserving health-care liquor which is low in drinking amount every time and easy to absorb; and carrying out freeze drying on the separated macromolecular material liquid with the molecular weight larger than 50,000 and red ginseng, hedysarum polybotrys, fructus psoraleae and cistanche deserticola material liquid extracted with water, then processing into the health-preserving health-care granules, or processing into tablets and pills. The wastes are reprocessed, fully utilized, and turned into wealth, the best use of materials is achieved, the wastes can be prevented, cost can be saved, and environmental pollution can be reduced.
Owner:郭建斌

Traditional Chinese medicine decoction for treating diabetic nephropathy and preparation method of traditional Chinese medicine decoction

InactiveCN105288155ASignificant effect in the treatment of diabetic nephropathyMetabolism disorderUrinary disorderPuerarinWolfiporia extensa
The invention relates to a traditional Chinese medicine decoction for treating diabetic nephropathy and a preparation method of the traditional Chinese medicine decoction. The traditional Chinese medicine decoction is mainly prepared from the following raw materials in parts by weight: 5-10 parts of polygonatum kingianum, 12-20 parts of radix ophiopogonis, 10-16 parts of puerarin, 3-9 parts of kalmegh, 4-12 parts of rhizoma atractylodis macrocephalae, 5-11 parts of poria cocos, 6-13 parts of flatstem milkvetch seeds, 2-6 parts of morinda officinalis, 7-15 parts of oldenlandia diffusa, 3-7 parts of fruits of belleric terminalia, 1-5 parts of dragon's blood, 3-10 parts of szechwan Chinaberry fruits, 10-18 parts of hedysarum polybotrys and 5-13 parts of siphonostegia chinensis. The traditional Chinese medicine decoction disclosed by the invention has a significant treatment effect on diabetic nephropathy, and is reasonable in compatibility and unique in composition; and a plurality of medicines work together to reach the efficacies of clearing heat, moistening dryness, nourishing yin, generating body fluid, warmly invigorating spleen and kidneys, invigorating the spleen, supplementing qi, clearing and activating the channels and collaterals, moistening the lung, clearing away the heart-fire and the like; the effective rate is 93.3%; and the traditional Chinese medicine decoction is very suitable for patients with diabetic nephropathy for taking.
Owner:济南超舜中药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products